Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 4277256
[patent_doc_number] => 06281207
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-28
[patent_title] => 'Treatment of movement disorders by administration of mirtazapine'
[patent_app_type] => 1
[patent_app_number] => 9/396335
[patent_app_country] => US
[patent_app_date] => 1999-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5871
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/281/06281207.pdf
[firstpage_image] =>[orig_patent_app_number] => 396335
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/396335 | Treatment of movement disorders by administration of mirtazapine | Sep 14, 1999 | Issued |
Array
(
[id] => 4249409
[patent_doc_number] => 06221887
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-24
[patent_title] => 'Treatment of inflammatory disorders with NMDA antagonists and sodium channel antagonists'
[patent_app_type] => 1
[patent_app_number] => 9/380988
[patent_app_country] => US
[patent_app_date] => 1999-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1292
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/221/06221887.pdf
[firstpage_image] =>[orig_patent_app_number] => 380988
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/380988 | Treatment of inflammatory disorders with NMDA antagonists and sodium channel antagonists | Sep 12, 1999 | Issued |
Array
(
[id] => 4327422
[patent_doc_number] => 06329414
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Histidine containing nutriceutical'
[patent_app_type] => 1
[patent_app_number] => 9/393891
[patent_app_country] => US
[patent_app_date] => 1999-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9480
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/329/06329414.pdf
[firstpage_image] =>[orig_patent_app_number] => 393891
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/393891 | Histidine containing nutriceutical | Sep 9, 1999 | Issued |
Array
(
[id] => 4184283
[patent_doc_number] => 06150353
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders'
[patent_app_type] => 1
[patent_app_number] => 9/380723
[patent_app_country] => US
[patent_app_date] => 1999-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2396
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/150/06150353.pdf
[firstpage_image] =>[orig_patent_app_number] => 380723
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/380723 | Therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders | Sep 6, 1999 | Issued |
Array
(
[id] => 1521054
[patent_doc_number] => 06413961
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Irrigation solution and method for inhibition of pain and inflammation'
[patent_app_type] => B1
[patent_app_number] => 09/388837
[patent_app_country] => US
[patent_app_date] => 1999-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 28164
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/413/06413961.pdf
[firstpage_image] =>[orig_patent_app_number] => 09388837
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/388837 | Irrigation solution and method for inhibition of pain and inflammation | Aug 31, 1999 | Issued |
Array
(
[id] => 4320429
[patent_doc_number] => 06248745
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-19
[patent_title] => 'Pharmaceutical combination comprising a COX-2 inhibitor and a iNOS inhibitor'
[patent_app_type] => 1
[patent_app_number] => 9/380379
[patent_app_country] => US
[patent_app_date] => 1999-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4450
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 739
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/248/06248745.pdf
[firstpage_image] =>[orig_patent_app_number] => 380379
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/380379 | Pharmaceutical combination comprising a COX-2 inhibitor and a iNOS inhibitor | Aug 31, 1999 | Issued |
Array
(
[id] => 1533123
[patent_doc_number] => 06410540
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Inhibitors of p38-kinase'
[patent_app_type] => B1
[patent_app_number] => 09/385494
[patent_app_country] => US
[patent_app_date] => 1999-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8533
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410540.pdf
[firstpage_image] =>[orig_patent_app_number] => 09385494
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/385494 | Inhibitors of p38-kinase | Aug 26, 1999 | Issued |
Array
(
[id] => 1521057
[patent_doc_number] => 06413962
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Guanidino compounds effective as anesthetics'
[patent_app_type] => B1
[patent_app_number] => 09/377878
[patent_app_country] => US
[patent_app_date] => 1999-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19138
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/413/06413962.pdf
[firstpage_image] =>[orig_patent_app_number] => 09377878
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/377878 | Guanidino compounds effective as anesthetics | Aug 18, 1999 | Issued |
Array
(
[id] => 7001098
[patent_doc_number] => 20010053797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-20
[patent_title] => 'MODULATION OF N-METHYL-D-ASPARTATE RECEPTOR RESPONSES WITH S-SUBSTITUTED DERIVATIVES OF GLUTATHIONE'
[patent_app_type] => new
[patent_app_number] => 09/376530
[patent_app_country] => US
[patent_app_date] => 1999-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6121
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20010053797.pdf
[firstpage_image] =>[orig_patent_app_number] => 09376530
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/376530 | Modulation of N-methyl-D-aspartate receptor responses with S-substituted derivatives of glutathione | Aug 17, 1999 | Issued |
Array
(
[id] => 4346331
[patent_doc_number] => 06284757
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Pyrrolo[1,2-a]pyrazine derivatives as 5HT1A ligands'
[patent_app_type] => 1
[patent_app_number] => 9/372438
[patent_app_country] => US
[patent_app_date] => 1999-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14970
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 268
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284757.pdf
[firstpage_image] =>[orig_patent_app_number] => 372438
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/372438 | Pyrrolo[1,2-a]pyrazine derivatives as 5HT1A ligands | Aug 10, 1999 | Issued |
Array
(
[id] => 4323573
[patent_doc_number] => 06331571
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-18
[patent_title] => 'Methods of treating and preventing attention deficit disorders'
[patent_app_type] => 1
[patent_app_number] => 9/372158
[patent_app_country] => US
[patent_app_date] => 1999-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16628
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/331/06331571.pdf
[firstpage_image] =>[orig_patent_app_number] => 372158
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/372158 | Methods of treating and preventing attention deficit disorders | Aug 10, 1999 | Issued |
09/230367 | PHARMACEUTICAL COMPOSITION CONTAINING A 5HT2C ANTAGONIST AND A D2 ANTAGONIST | Aug 10, 1999 | Abandoned |
Array
(
[id] => 4406945
[patent_doc_number] => 06232311
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-15
[patent_title] => 'Method for treating or preventing psychosomatic and psychoimmunologic disorders'
[patent_app_type] => 1
[patent_app_number] => 9/371394
[patent_app_country] => US
[patent_app_date] => 1999-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18316
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/232/06232311.pdf
[firstpage_image] =>[orig_patent_app_number] => 371394
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/371394 | Method for treating or preventing psychosomatic and psychoimmunologic disorders | Aug 9, 1999 | Issued |
Array
(
[id] => 4296183
[patent_doc_number] => 06184236
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-06
[patent_title] => 'Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative'
[patent_app_type] => 1
[patent_app_number] => 9/370602
[patent_app_country] => US
[patent_app_date] => 1999-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16005
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/184/06184236.pdf
[firstpage_image] =>[orig_patent_app_number] => 370602
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/370602 | Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative | Aug 8, 1999 | Issued |
09/351949 | METHOD OF TREATMENT FOR DECREASING MORTALITY RESULTING FROM CONGESTIVE HEART FAILURE | Jul 11, 1999 | Abandoned |
Array
(
[id] => 4409855
[patent_doc_number] => 06300332
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-09
[patent_title] => 'Methods for reducing respiratory depression and attendant side effects of mu opioid compounds'
[patent_app_type] => 1
[patent_app_number] => 9/352308
[patent_app_country] => US
[patent_app_date] => 1999-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21161
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/300/06300332.pdf
[firstpage_image] =>[orig_patent_app_number] => 352308
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/352308 | Methods for reducing respiratory depression and attendant side effects of mu opioid compounds | Jul 11, 1999 | Issued |
Array
(
[id] => 4360375
[patent_doc_number] => 06169098
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-02
[patent_title] => 'Composition and methods employing it for the treatment of 5-HT-mediated disorders'
[patent_app_type] => 1
[patent_app_number] => 9/351069
[patent_app_country] => US
[patent_app_date] => 1999-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2263
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/169/06169098.pdf
[firstpage_image] =>[orig_patent_app_number] => 351069
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/351069 | Composition and methods employing it for the treatment of 5-HT-mediated disorders | Jul 8, 1999 | Issued |
Array
(
[id] => 4383878
[patent_doc_number] => 06262081
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-17
[patent_title] => 'Composition for and method of treating neurological disorders'
[patent_app_type] => 1
[patent_app_number] => 9/349906
[patent_app_country] => US
[patent_app_date] => 1999-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6409
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/262/06262081.pdf
[firstpage_image] =>[orig_patent_app_number] => 349906
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/349906 | Composition for and method of treating neurological disorders | Jul 7, 1999 | Issued |
09/319507 | REMEDIES/PREVENTIVES FOR ABNORMAL MOTIONS ACCOMPANYING DISORDERS IN EXTRAPYRAMIDAL SYSTEM | Jul 6, 1999 | Abandoned |
Array
(
[id] => 4410762
[patent_doc_number] => 06228888
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitors'
[patent_app_type] => 1
[patent_app_number] => 9/345782
[patent_app_country] => US
[patent_app_date] => 1999-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14776
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/228/06228888.pdf
[firstpage_image] =>[orig_patent_app_number] => 345782
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/345782 | Methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitors | Jun 30, 1999 | Issued |